2 results
Selected Clinical Trials of SGLT2 inhibitors in CVD and CKD
EMPA-REG OUTCOME - Empagliflozin lowered CV events
in HF and CKD. ... in HFrEF on GDMT ... outcomes in HFrEF ... #inhibitors #EBM ... #table #CVD #CKD
Stages in the development of HF and recommended therapy by stage. ACEI indicates angiotensin-converting enzyme inhibitor;
ejection fraction; GDMT ... HFpEF, heart failure ... ejection fraction; HFrEF ... #CHF #Congestive ... Staging #Stages #ACCAHA